Profil
Suneel Gupta worked at ALZA Corp.
from 1989 to 2001 as VP-Clinical Pharmacology & Product Discovery.
From 2002 to 2008, worked at Johnson & Johnson as Senior Vice President.
From 2008 to 2019, worked at Impax Pharmaceuticals, Inc. as Chief Scientific Officer.
From 2025 to 2026, worked at Protagonist Therapeutics, Inc. as Executive Vice President-Clinical Development.
Dr. Gupta earned a doctorate from The University of Manchester in 1987.
Ehemalige bekannte Positionen von Suneel Gupta
| Unternehmen | Position | Ende |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2026 |
Impax Pharmaceuticals, Inc.
Impax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2019 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01.01.2008 |
| ALZA CORPORATION | Corporate Officer/Principal | 01.01.2001 |
Ausbildung von Suneel Gupta
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
ALZA Corp.
ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
The University of Manchester
The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Impax Pharmaceuticals, Inc.
Impax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
















